The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
The chemokine receptors CXCR3 and CCR5 mark subsets of T cells associated with certain inflammatory reactions.
Open accessAbstract
T cells infiltrating inflammatory sites are usually of the activated/memory type. The precise mechanism for the positioning of these cells within tissues is unclear. Adhesion molecules certainly play a role; however, the intricate control of cell migration appears to be mediated by numerous chemokines and their receptors. Particularly important chemokines for activated/memory T cells are the CXCR3 ligands IP-10 and Mig and the CCR5 ligands RANTES, macrophage inflammatory protein-1alpha, and macrophage inflammatory protein-1beta. We raised anti-CXCR3 mAbs and were able to detect high levels of CXCR3 expression on activated T cells. Surprisingly, a proportion of circulating blood T cells, B cells, and natural killer cells also expressed CXCR3. CCR5 showed a similar expression pattern as CXCR3, but was expressed on fewer circulating T cells. Blood T cells expressing CXCR3 (and CCR5) were mostly CD45RO+, and generally expressed high levels of beta1 integrins. This phenotype resembled that of T cells infiltrating inflammatory lesions. Immunostaining of T cells in rheumatoid arthritis synovial fluid confirmed that virtually all such T cells expressed CXCR3 and approximately 80% expressed CCR5, representing high enrichment over levels of CXCR3+ and CCR5+ T cells in blood, 35 and 15%, respectively. Analysis by immunohistochemistry of various inflamed tissues gave comparable findings in that virtually all T cells within the lesions expressed CXCR3, particularly in perivascular regions, whereas far fewer T cells within normal lymph nodes expressed CXCR3 or CCR5. These results demonstrate that the chemokine receptor CXCR3 and CCR5 are markers for T cells associated with certain inflammatory reactions, particularly TH-1 type reactions. Moreover, CXCR3 and CCR5 appear to identify subsets of T cells in blood with a predilection for homing to these sites.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“CCR5, another chemokine receptor with similar homing properties, has been also used to identify these cells [144, 145], but it is expressed only on the more differentiated Th1 effector memory population [146].”
From Guidelines for the use of flow cytometry and cell sorting in immunological studies (third edition) (2021) · cites this paper as [145]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Traffic signals for lymphocyte recirculation and leukocyte emigration: The multistep paradigm
Springer, T. A. (1994) · Cell · doi:10.1016/0092-8674(94)90337-9 · Cited by 7,009
Current Protocols in Immunology
(2018) · Current Protocols in Immunology · doi:10.1002/(issn)1934-368x · Cited by 3,574
Lymphocyte Homing and Homeostasis
Butcher, E. C., & Picker, L. J. (1996) · Science · doi:10.1126/science.272.5258.60 · Cited by 2,846
Baggiolini, M., Dewald, B., & Moser, B. (1997) · Annual Review of Immunology · doi:10.1146/annurev.immunol.15.1.675 · Cited by 2,193
Self-citationThe lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry
Bleul, C. C., Farzan, M., Choe, H., Parolin, C., Clark‐Lewis, I., Sodroski, J., & Springer, T. A. (1996) · Nature · doi:10.1038/382829a0 · Cited by 1,953
Oberlin, E., Amara, A., Bachelerie, F., Chable-Bessia, C., Virelizier, J., Arenzana‐Seisdedos, F., Schwartz, O., Heard, J., Clark‐Lewis, I., Legler, D. F., et al. (1996) · Nature · doi:10.1038/382833a0 · Cited by 1,652
Self-citationA highly efficacious lymphocyte chemoattractant, stromal cell-derived factor 1 (SDF-1)
Bleul, C. C., Fuhlbrigge, R. C., Casasnovas, J. M., Aiuti, A., & Springer, T. A. (1996) · The Journal of experimental medicine · doi:10.1084/jem.184.3.1101 · Cited by 1,482
Current protocols in immunology
Nezlin, R. S. (1992) · Molecular Immunology · doi:10.1016/0161-5890(92)90114-d · Cited by 1,413
Selective attraction of monocytes and T lymphocytes of the memory phenotype by cytokine RANTES
Schall, T. J., Bacon, K. B., Toy, K. J., & Goeddel, D. V. (1990) · Nature · doi:10.1038/347669a0 · Cited by 1,378
Loetscher, M., Gerber, B., Loetscher, P., Jones, S. A., Piali, L., Clark-Lewis, I., Baggiolini, M., & Moser, B. (1996) · Journal of Experimental Medicine · doi:10.1084/jem.184.3.963 · Cited by 1,333
Self-citation
Cited by
Sorted by citations
Items 601–700 of 1,000
Kivisäkk, P., Tucky, B. H., Wei, T., Campbell, J. J., & Ransohoff, R. M. (2006) · BMC Immunology · doi:10.1186/1471-2172-7-14 · Cited by 45
Identification and initial evaluation of 4-N-aryl-[1,4]diazepane ureas as potent CXCR3 antagonists
Cole, A. G., Stroke, I. L., Brescia, M., Simhadri, S. R., Zhang, J. J., Hussain, Z., Snider, M. C., Haskell, C. A., Ribeiro, S., Appell, K. C., et al. (2005) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2005.09.020 · Cited by 45
CCL 2 and CXCL 10 are associated with poor outcome after intracerebral hemorrhage
Landreneau, M. J., Mullen, M. T., Messe, S. R., Cucchiara, B. L., Sheth, K. N., McCullough, L. D., Kasner, S. E., Sansing, L. H., & the Serum Markers After Spontaneous Cerebral Hemorrhage (SMASCH) Investigators (2018) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.595 · Cited by 44
Li, J., Ybarra, R., Mak, J., Hérault, A., de Almeida, P. E., Arrazate, A., Ziai, J. M., Tótpál, K., Junttila, M. R., Walsh, K. B., et al. (2018) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-18-1139 · Cited by 45
A Novel Multi-Biomarker Assay for Non-Invasive Quantitative Monitoring of Kidney Injury
Watson, D., Yang, J., Sarwal, R. D., Sigdel, T. K., Liberto, J. M., Damm, I., Louie, V., Sigdel, S., Livingstone, D. M., Soh, K. K., et al. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8040499 · Cited by 44
Saluzzo, S., Pandey, R. V., Gail, L. M., Dingelmaier‐Hovorka, R., Kleißl, L., Shaw, L. E., Reininger, B., Atzmüller, D., Strobl, J., Touzeau‐Römer, V., et al. (2021) · Immunity · doi:10.1016/j.immuni.2021.10.021 · Cited by 46
Chen, X., Oppenheim, J. J., & Howard, O. M. Z. (2004) · PubMed · Cited by 44
de Groot, M., Teunissen, M. B. M., Ortonne, J. P., Lambert, J. R., Naeyaert, J. M., Picavet, D. I., Arreaza, M. G., Simon, J. S., Kraan, M. C., Bos, J. D., et al. (2007) · Archives of Dermatological Research · doi:10.1007/s00403-007-0764-7 · Cited by 44
Chemokine inhibition in inflammatory arthritis
Tak, P. P. (2006) · Best Practice & Research Clinical Rheumatology · doi:10.1016/j.berh.2006.06.001 · Cited by 45
Stańczyk, J., Kowalski, M. L., Grzegorczyk, J. Ł., Szkudlińska, B., Jarzębska, M., Marciniak, M., & Synder, M. A. (2005) · Mediators of Inflammation · doi:10.1155/mi.2005.343 · Cited by 44
Hill, N. J., Gunst, K. V., & Sarvetnick, N. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.4.1649 · Cited by 44
Okazaki, H., Kakurai, M., Hirata, D., Satō, H., Kamimura, T., Onai, N., Matsushima, K., Nakagawa, H., Kano, S., & Minota, S. (2002) · Clinical & Experimental Allergy · doi:10.1046/j.1365-2745.2002.01383.x · Cited by 44
Pathogen-specific T cell depletion and reactivation of opportunistic pathogens in HIV infection
Geldmacher, C., & Koup, R. A. (2012) · Trends in Immunology · doi:10.1016/j.it.2012.01.011 · Cited by 46
Interstitial inflammation in Alport syndrome
Jedlička, J., Soleiman, A., Draganovici, D., Mandelbaum, J., Ziegler, U., Regele, H. M., Wuthrich, R. P., Groß, O., Anders, H., & Segerer, S. (2009) · Human Pathology · doi:10.1016/j.humpath.2009.08.024 · Cited by 43
CXCL10 suppression of hem- and lymph-angiogenesis in inflamed corneas through MMP13
Gao, N., Liu, X., Wu, J., Li, J., Dong, C., Wu, X., Xiao, X., & Yu, F. X. (2017) · Angiogenesis · doi:10.1007/s10456-017-9561-x · Cited by 43
T Helper Cell Infiltration in Osteoarthritis-Related Knee Pain and Disability
Nees, T. A., Rosshirt, N., Zhang, J. A., Platzer, H., Sorbi, R., Tripel, E., Reiner, T., Walker, T., Schiltenwolf, M., Lorenz, H., et al. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9082423 · Cited by 43
Jones, D., Fletcher, C. D. �., Pulford, K. A. F., Shahsafaei, A., & Dorfman, D. M. (1999) · Blood · doi:10.1182/blood.v93.10.3487.410k39_3487_3493 · Cited by 43
Chen, S., de Groot, M., Kinsley, D., Laverty, M., McClanahan, T. K., Arreaza, M. G., Gustafson, E. L., Teunissen, M. B. M., de Rie, M. A., Fine, J. S., et al. (2009) · Archives of Dermatological Research · doi:10.1007/s00403-009-0966-2 · Cited by 42
Satarkar, D., & Patra, C. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.882017 · Cited by 42
Woodfolk, J. A., & Platts‐Mills, T. A. E. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.9.5412 · Cited by 42
Qin, S., Alcorn, J. F., Craigo, J. K., Tjoeng, C., Tarwater, P. M., Kolls, J. K., & Reinhart, T. A. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1002876 · Cited by 42
Self-citationApolinario, A., Moisés Diago, M., Iacono, O. L., Lorente, R., Pérez, C., Majano, P. L., Clemente, G., & García‐Monzón, C. (2004) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2004.01872.x · Cited by 42
Immune Traffic: A Functional Overview
Beilhack, A., & Rockson, S. G. (2003) · Lymphatic Research and Biology · doi:10.1089/153968503768330256 · Cited by 42
Furuya, M., Yoneyama, T., Miyagi, E., Tanaka, R. J., Nagahama, K., Miyagi, Y., Nagashima, Y., Hirahara, F., Inayama, Y., & Aoki, I. (2011) · Gynecologic Oncology · doi:10.1016/j.ygyno.2011.05.034 · Cited by 43
Ellingsen, T., Hornung, N., Moller, B. K., Poulsen, J. H., & Stengaard‐Pedersen, K. (2006) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2006.054056 · Cited by 42
Wedderburn, L. R., Maini, M. K., Patel, A., Beverley, P. C. L., & Woo, P. M. (1999) · International Immunology · doi:10.1093/intimm/11.4.535 · Cited by 42
Brühl, H., Cihak, J., Stangassinger, M., Schlöndorff, D., & Mack, M. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.4.2420 · Cited by 42
McInnes, I. B. (2001) · Rheumatic Disease Clinics of North America · doi:10.1016/s0889-857x(05)70207-6 · Cited by 42
Role of Chemokines in the Regulation of Th1/Th2 and Autoimmune Encephalomyelitis
Kennedy, K. J., & Karpus, W. J. (1999) · Journal of Clinical Immunology · doi:10.1023/a:1020535423465 · Cited by 42
Ebert, L. M., & McColl, S. R. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.8.4870 · Cited by 42
Al-Banna, N., Vaci, M., Slauenwhite, D., Johnston, B., & Issekutz, T. B. (2014) · European Journal of Immunology · doi:10.1002/eji.201343995 · Cited by 41
Immune Monitoring of Kidney Allografts
Ho, J., Wiebe, C., Gibson, I. W., Rush, D. N., & Nickerson, P. W. (2012) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2012.01.028 · Cited by 41
Mankowski, R. T., Anton, S. D., Ghita, G. L., Brumback, B., Darden, D. B., Bihorac, A., Leeuwenburgh, C., Moldawer, L. L., Efron, P. A., Brakenridge, S. C., et al. (2021) · The Journals of Gerontology Series A · doi:10.1093/gerona/glab080 · Cited by 41
Kawaguchi, M., Kokubu, F., Huang, S.-K., Homma, T., Odaka, M., Watanabe, S., Suzuki, S., Ieki, K., Matsukura, S., Kurokawa, M., et al. (2007) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2007.02.036 · Cited by 41
Berrebi, D. D., Languepin, J., Ferkdadji, L., Foussat, A., Lagausie, P. P. D., Paris, R., Émilie, D., Mougenot, J. F., Cézard, J., Navarro, J., et al. (2003) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1002/j.1536-4801.2003.tb11998.x · Cited by 41
Norii, M., Yamamura, M., Iwahashi, M., Ueno, A., Yamana, J., & Makino, H. (2006) · PubMed · doi:10.18926/amo/30745 · Cited by 41
Chemokine Receptor Expression in Human Endometrium1
Mülayim, N., Palter, S. F., Kayisli, U. A., Senturk, L. M., & Arici, A. M. (2003) · Biology of Reproduction · doi:10.1095/biolreprod.102.009639 · Cited by 41
Pathogen Evasion of Chemokine Response Through Suppression of CXCL10
Antonia, A. L., Alvarez, M. I., Trahair, E. D., Gibbs, K. D., Pittman, K. J., Barnes, A. B., Smith, J. S., Rajagopal, S., Thompson, J. W., Reinhardt, R. L., et al. (2019) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2019.00280 · Cited by 41
Park, M. K., Hoffmann, K. F., Cheever, A. W., Amichay, D., Wynn, T. A., & Farber, J. M. (2001) · Infection and Immunity · doi:10.1128/iai.69.11.6755-6768.2001 · Cited by 42
The difficulty in diagnosis of pulmonary embolism
Wilkinson, T. M. A. (2003) · Thorax · doi:10.1136/thorax.58.1.29 · Cited by 41
The Role of Chemokine Receptors in Directing Traffic of Naive, Type 1 and Type 2 T Cells
Sallusto, F., Palermo, B., Hoy, A., & Lanzavecchia, A. (1999) · Current topics in microbiology and immunology · doi:10.1007/978-3-642-60162-0_16 · Cited by 41
Lun, S. W., Wong, C. K., Ko, F. W. S., Hui, D. S. C., & Lam, C. W. K. (2007) · Journal of Clinical Immunology · doi:10.1007/s10875-007-9093-z · Cited by 40
Analysis of CXCL9 and CXCR3 expression in a case of intravascular large B-cell lymphoma
Kato, M., Ohshima, K., Mizuno, M., Kyogoku, M., Hashikawa, K., TOKURA, Y., Miyachi, Y., & Kabashima, K. (2009) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2009.02.007 · Cited by 40
Kraft, M., Riedel, S., Maaser, C., Kucharzik, T. F., Steinbüchel, A., Domschke, W., & Luegering, N. (2001) · Clinical & Experimental Immunology · doi:10.1046/j.1365-2249.2001.01634.x · Cited by 40
Rosenblum, J., Zhang, Q.-W., Siu, G., Collins, T. L., Sullivan, T., Dairaghi, D. J., Medina, J. C., & Fairchild, R. L. (2009) · Transplantation · doi:10.1097/tp.0b013e31819574e9 · Cited by 40
Widney, D. P., Hu, Y., Foreman-Wykert, A. K., Bui, K. C., Nguyen, T. T., Lu, B., Gerard, C. J., Miller, J. F., & Smith, J. B. (2004) · Infection and Immunity · doi:10.1128/iai.73.1.485-493.2005 · Cited by 40
Chemokine Receptor Expressions and Responsiveness of Cord Blood T Cells
Sato, K., Kawasaki, H., Nagayama, H., Enomoto, M., Morimoto, C., Tadokoro, K., Juji, T., & Takahashi, T. A. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.3.1659 · Cited by 40
Are T cells in rheumatoid synovium aggressors or bystanders?
Miossec, P. (2000) · Current Opinion in Rheumatology · doi:10.1097/00002281-200005000-00004 · Cited by 40
The Immune System—A Hidden Treasure for Biomarker Discovery in Cutaneous Melanoma
Neagu, M. T. (2012) · Advances in clinical chemistry · doi:10.1016/b978-0-12-394383-5.00011-4 · Cited by 39
Expression of chemokine receptors in vernal keratoconjunctivitis
El-Asrar, A. M. A. (2001) · British Journal of Ophthalmology · doi:10.1136/bjo.85.11.1357 · Cited by 39
Yun, C.-S., Choi, Y., Jeong, M., Lee, J.-H., & Lim, S. (2012) · Journal of Natural Medicines · doi:10.1007/s11418-012-0714-3 · Cited by 39
Genetic polymorphisms of CC chemokine receptor 3 in Japanese and British asthmatics
Fukunaga, K., Asano, K., Mao, X. ‐., Gao, P., Roberts, M. H., Oguma, T., Shiomi, T., Kanazawa, M., Adra, C. N., Shirakawa, T., et al. (2001) · European Respiratory Journal · doi:10.1183/09031936.01.17100590 · Cited by 39
Suefuji, H., Ohshima, K., Karube, K., Kawano, R., Nabeshima, K., Suzumiya, J., Hayabuchi, N., & Kikuchi, M. (2005) · International Journal of Cancer · doi:10.1002/ijc.20823 · Cited by 39
Chemoattractant Receptors Expressed on Type 2 T Cells and Their Role in Disease
Cosmi, L., Annunziato, F., Maggi, E., Romagnani, S., & Manetti, R. (2001) · International Archives of Allergy and Immunology · doi:10.1159/000053827 · Cited by 39
VIP and PACAP down-regulate CXCL10 (IP-10) and up-regulate CCL22 (MDC) in spleen cells
Jiang, X., Jing, H., & Ganea, D. (2002) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(02)00365-x · Cited by 39
Poluektova, L. Y., Moran, T., Zelivyanskaya, M. L., Swindells, S., Gendelman, H. E., & Persidsky, Y. (2001) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(01)00413-1 · Cited by 39
Effects of the CCR5-Δ32 mutation on antiviral treatment in chronic hepatitis C
Ahlenstiel, G., Berg, T., Woitas, R. P., Grünhage, F., Iwan, A., Heß, L., Brackmann, H. H., Kupfer, B., Schernick, A., Sauerbruch, T., et al. (2003) · Journal of Hepatology · doi:10.1016/s0168-8278(03)00193-4 · Cited by 39
Trajerová, M., Kriegová, E., Mikulková, Z., Savara, J., Kudělka, M., & Gallo, J. (2022) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2022.08.019 · Cited by 38
Evidence for PI-3K-dependent migration of Th17-polarized cells in response to CCR2 and CCR6 agonists
Webb, A., Johnson, A., Fortunato, M., Platt, A., Crabbe, T., Christie, M. I., Watt, G. F., Ward, S. G., & Jopling, L. A. (2008) · Journal of Leukocyte Biology · doi:10.1189/jlb.0408234 · Cited by 40
Dual role for CXCR3 and CCR5 in asthmatic type 1 inflammation
Gauthier, M. C., Kale, S. L., Oriss, T. B., Scholl, K., Das, S., Yuan, H., Hu, S., Chen, J., Camiolo, M. J., Ray, P., et al. (2021) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2021.05.044 · Cited by 38
Molecular mechanisms of cholangiopathy in primary biliary cirrhosis
Harada, K., & Nakanuma, Y. (2006) · Medical Molecular Morphology · doi:10.1007/s00795-006-0321-z · Cited by 38
Fierro, M. T., Comessatti, A., Quaglino, P., Ortoncelli, M., Osella‐Abate, S., Ponti, R., Novelli, M., & Bernengo, M. G. (2006) · Dermatology · doi:10.1159/000096191 · Cited by 38
CCL5: A Double-Edged Sword in Host Defense Against the Hepatitis C Virus
Katsounas, A., Schlaak, J., & Lempicki, R. A. (2011) · International Reviews of Immunology · doi:10.3109/08830185.2011.593105 · Cited by 40
Francis, J. N., Lloyd, C. M., Sabroe, I., Durham, S. R., & Till, S. J. (2006) · Allergy · doi:10.1111/j.1398-9995.2006.01253.x · Cited by 38
Torvinen, M., Campwala, H., & Kilty, I. (2007) · Respiratory Research · doi:10.1186/1465-9921-8-80 · Cited by 38
Alternative Medicines as Emerging Therapies for Inflammatory Bowel Diseases
Singh, U. P., Singh, N. P., Busbee, P. B., Guan, H., Singh, B., Price, R. L., Taub, D. D., Mishra, M. K., Nagarkatti, M., & Nagarkatti, P. S. (2012) · International Reviews of Immunology · doi:10.3109/08830185.2011.642909 · Cited by 40
Francis, J. N., Sabroe, I., Lloyd, C. M., Durham, S. R., & Till, S. J. (2008) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2008.03657.x · Cited by 38
Desensitization of T lymphocyte function by CXCR3 ligands in human hepatocellular carcinoma
Liu, Y. (2005) · World Journal of Gastroenterology · doi:10.3748/wjg.v11.i2.164 · Cited by 38
Wiley, R. E., Palmer, K., Gajewska, B., Stämpfli, M. R., Álvarez, D., Coyle, A. J., Gutierrez-Ramos, J.-C., & Jordana, M. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.4.2750 · Cited by 38
Discovery of small molecule benzimidazole antagonists of the chemokine receptor CXCR3
Hayes, M. E., Wallace, G. A., Grongsaard, P., Bischoff, A. K., George, D. M., Miao, W., McPherson, M. J., Stoffel, R. H., Green, D. W., & Roth, G. P. (2008) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2008.01.074 · Cited by 37
Adeyemi, J. A., Harmon, D. L., Compart, D. M., & Ogunade, I. M. (2019) · Journal of Animal Science · doi:10.1093/jas/skz308 · Cited by 37
Repurposing Anti-Cancer Drugs for COVID-19 Treatment
Borcherding, N. C., Jethava, Y. S., & Vikas, P. (2020) · Drug Design Development and Therapy · doi:10.2147/dddt.s282252 · Cited by 37
Expression of CC and CXC chemokines and chemokine receptors in human leprosy skin lesions
Aa, K., MUSONDA, A. C., Khanolkar-Young, S., Suneetha, S. K., & Lockwood, D. N. J. (2003) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2003.02306.x · Cited by 37
Liu, Y., Poon, R. T. P., Hughes, J., Feng, X., Yu, W. C., & Fan, S. T. (2004) · Clinical Immunology · doi:10.1016/j.clim.2004.10.006 · Cited by 37
Sun, Y., Finger, C., Álvarez‐Vallina, L., Cichutek, K., & Buchholz, C. J. (2005) · Cancer Gene Therapy · doi:10.1038/sj.cgt.7700854 · Cited by 37
A Mandatory Role for STAT4 in IL-12 Induction of Mouse T Cell CCR5
岩崎, 正., Mukai, T., Nakajima, C., Yang, Y., Gao, P. H., Yamaguchi, N., Tomura, M., Fujiwara, H., & Hamaoka, T. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.12.6877 · Cited by 37
Expression of the chemokine receptor CXCR3 in human renal allografts—a prospective study
Hoffmann, U., Segerer, S., Rümmele, P., Krüger, B., Pietrzyk, M. C., Hofstädter, F., Banas, B., & Krämer, B. K. (2006) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfk075 · Cited by 37
Cantoni, C., Bottino, C., Augugliaro, R., Morelli, L., Marcenaro, E., Castriconi, R., Vitale, M., Pende, D., Sivori, S., Millo, R., et al. (1999) · European Journal of Immunology · doi:10.1002/(sici)1521-4141(199910)29:10 · Cited by 153
Ohtani, N., Ohtani, H., Nakayama, T., Naganuma, H., Sato, E., Imai, T., Nagura, H., & Yoshie, O. (2004) · Laboratory Investigation · doi:10.1038/labinvest.3700039 · Cited by 37
Targeting cell migration in rheumatoid arthritis
Asquith, D. L., Bryce, S. A., & Nibbs, R. J. B. (2015) · Current Opinion in Rheumatology · doi:10.1097/bor.0000000000000150 · Cited by 36
Romano, C. P., Sellitto, A., Fanis, U. D., Balestrieri, A., Savoia, A., Abbadessa, S., Astarita, C., & Lucivero, G. (2015) · Clinical Drug Investigation · doi:10.1007/s40261-015-0267-9 · Cited by 36
Diagnostic value of urinary CXCL10 as a biomarker for predicting Hunner type interstitial cystitis
Niimi, A., Igawa, Y., Aizawa, N., Honma, T., Nomiya, A., Akiyama, Y., Kamei, J., Fujimura, T., Fukuhara, H., & Homma, Y. (2017) · Neurourology and Urodynamics · doi:10.1002/nau.23431 · Cited by 36
Therapeutic and Diagnostic Implications of T Cell Scarring in Celiac Disease and Beyond
Christophersen, A. O., Risnes, L. F., Dahal‐Koirala, S., & Sollid, L. M. (2019) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2019.05.009 · Cited by 36
Role of chemokines in breast cancer
Masih, M., Agarwal, S., Kaur, R., & Gautam, P. K. (2022) · Cytokine · doi:10.1016/j.cyto.2022.155909 · Cited by 36
Kabashima, H., Yoneda, M., Nagata, K., Hirofuji, T., Ishihara, Y., Yamashita, M., & Maeda, K. (2001) · Cytokine · doi:10.1006/cyto.2001.0947 · Cited by 36
Th1 (CXCL10) and Th2 (CCL2) chemokine expression in patients with immune thrombocytopenia
Gu, D., Chen, Z., Zhao, H., Du, W., Xue, F., Ge, J., Sui, T., Wu, H., Liu, B., Lu, S., et al. (2010) · Human Immunology · doi:10.1016/j.humimm.2010.02.010 · Cited by 36
Chen, L., & Sendo, F. (2001) · Parasitology International · doi:10.1016/s1383-5769(01)00063-0 · Cited by 36
Papadakis, K. A., Prehn, J., Zhu, D., Landers, C. J., Gaiennie, J., Fleshner, P. R., & Targan, S. R. (2004) · Inflammatory Bowel Diseases · doi:10.1097/00054725-200411000-00013 · Cited by 36
Cho, H., Shin, H. M., Haberstock-Debic, H., Xing, Y., Owens, T. D., Funk, J. O., Hill, R. J., Bradshaw, J. M., & Berg, L. J. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1501828 · Cited by 36
Six-Month Urinary CCL2 and CXCL10 Levels Predict Long-term Renal Allograft Outcome
Hirt‐Minkowski, P., Rush, D. N., Gao, A., Hopfer, H., Wiebe, C., Nickerson, P. W., Schaub, S., & Ho, J. (2016) · Transplantation · doi:10.1097/tp.0000000000001304 · Cited by 36
Innate immunity dictates cytokine polarization relevant to the development of pulmonary fibrosis
Strieter, R. M., & Keane, M. P. (2004) · Journal of Clinical Investigation · doi:10.1172/jci22398 · Cited by 36
Interleukin‐8 and CXCL10 expression in oral keratinocytes and fibroblasts via Toll‐like receptors
Fukui, A., Ohta, K., Nishi, H., Shigeishi, H., Tobiume, K., Takechi, M., & Kamata, N. (2012) · Microbiology and Immunology · doi:10.1111/1348-0421.12022 · Cited by 35
Chakraborty, K., Bose, A., Chakraborty, T., Sarkar, K., Goswami, S., Pal, S., & Baral, R. (2010) · Cellular and Molecular Immunology · doi:10.1038/cmi.2010.29 · Cited by 35
McGinn, O. J., Marinov, G., Sawan, S., & Stern, P. L. (2012) · Journal of Cell Science · doi:10.1242/jcs.109488 · Cited by 35
CCR5 Mediates Pro-osteoclastic and Osteoclastogenic Leukocyte Chemoattraction
Ferreira, S. B., Repeke, C. E. P., Raimundo, F. M., Nunes, I. S., Ávila-Campos, M. J., Ferreira, B. R., Silva, J. S., Campanelli, A. P., & Garlet, G. P. (2011) · Journal of Dental Research · doi:10.1177/0022034510395021 · Cited by 35
Carr, D. J. J., Wuest, T. R., & Ash, J. D. (2008) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2007.0110 · Cited by 35
Kawashima, D., Oshitani, N., Jinno, Y., Watanabe, K., Nakamura, S., Higuchi, K., & Arakawa, T. (2005) · Journal of Clinical Pathology · doi:10.1136/jcp.2004.024828 · Cited by 35
Dent, L. A. (2002) · Journal of Reproductive Immunology · doi:10.1016/s0165-0378(02)00017-7 · Cited by 35
Functional Interrogation of Primary Human T Cells via CRISPR Genetic Editing
Chen, X., Kozhaya, L., Taştan, C., Placek, L., Dogan, M., Horne, M., Abblett, R. L., Karhan, E., Vaeth, M., Feske, S., et al. (2018) · The Journal of Immunology · doi:10.4049/jimmunol.1701616 · Cited by 35
CC-chemokine receptor 5 (CCR5) in hepatitis C--at the crossroads of the antiviral immune response?
Ahlenstiel, G. (2004) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkh239 · Cited by 35
Metadata
- Authors
- Qin, S., Rottman, J. B., Myers, P., Kassam, N., Weinblatt, M., Loetscher, M., Koch, A. E., Moser, B., & Mackay, C. R.
- Affiliations
- Brigham and Women's Hospital (US)
- University of Bern (CH)
- Northwestern University (US)
- Venue
- Journal of Clinical Investigation
- Published
- 1998-02-15
- Volume
- 101
- Issue
- 4
- Pages
- 746-754
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC508621
- OpenAlex
- W2081596482
- Cited by
- 1,359
- References
- 39
- Citations by year
- 2026: 6 · 2025: 25 · 2024: 11 · 2023: 20 · 2022: 24 · 2021: 33 · 2020: 23 · 2019: 33 · 2018: 32 · 2017: 33 · 2016: 24 · 2015: 46 · 2014: 52 · 2013: 38 · 2012: 45
- FWCI
- 37.11
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Oncology › Chemokine receptors and signaling
- Health Sciences › Medicine › Immunology and Allergy › Cell Adhesion Molecules Research
- Life Sciences › Immunology and Microbiology › Immunology › Macrophage Migration Inhibitory Factor
- Keywords
- CXCR3, CCR5, chemokine receptors, T cell subsets, T cell homing, inflammatory cell infiltration, Th1 response, CXCL10, RANTES, CCL22, CCL19, CD45RO, beta1 integrin, T cell migration, lymph node T cells
- MeSH terms
- Animals, Antibodies, Monoclonal, Chemotaxis, Humans, Immunologic Memory, Inflammation, Leukocytes, Lymphocyte Activation, Lymphocytes, Mice, Inbred BALB C, Synovial Fluid, Tumor Cells, Cultured, Biomarkers, T-Lymphocyte Subsets, Chemokines, Receptors, Chemokine, Receptors, CCR5, Chemokines, CXC, Mice, Chemokine CXCL10, Receptors, CXCR3
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review